The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round
Dec 19, 2024•over 1 year ago
Contract Type
partnership
ArlingtonBiotechnologyArtificial Intelligence
Description
Portal Biotechnologies, Inc. has announced an oversubscribed $7M seed round led by IA Ventures and over 50 biopharma and academic partners utilizing its platform for various applications.
Company Information
Company
Portal
Location
Arlington, Massachusetts, United States
About
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics
ArlingtonBiotechnologyArtificial Intelligence